Patients on Eli Lilly's weight-loss drug Zepbound substantially regained weight nearly a year after stopping treatment, according to full results of a study published...
Eli Lilly and Co said on Thursday that the U.S. health regulator had approved Omvoh, its drug for treating adults with moderate-to-severe active ulcerative...
An experimental Alzheimer's drug developed by Eli Lilly slowed cognitive decline by 35% in a closely watched late-stage trial, the company said on Wednesday,...